Boston Scientific Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $15.85B | $35.14B | $865.0M |
| FY2024 | $17.63B | $39.40B | $414.0M |
| FY2025 | $19.44B | $43.67B | $1.97B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $15.85B | $35.14B | $865.0M |
| FY2024 | $17.63B | $39.40B | $414.0M |
| FY2025 | $19.44B | $43.67B | $1.97B |